Literature DB >> 17616438

Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?

Ursula Theuretzbacher1.   

Abstract

Despite the accepted knowledge that the activity of antibiotics depends on the unbound concentration at the site of infection, current pharmacodynamic analysis mostly relies on published total blood concentrations. Such concentrations do not necessarily correlate with concentrations at the site of infection. Methodological problems and separation of bound and unbound fractions, however, limit the applicability of most measured 'tissue concentrations' as adequate pharmacokinetic input into pharmacodynamic analyses. Recently, research on using free blood concentrations as surrogate concentrations has received more attention and may be useful for infection sites such as soft tissue infections. Although our understanding of antibiotic pharmacodynamics in tissues has become much more advanced, we are still lacking appropriate and accurate pharmacokinetic data derived from the site of infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616438     DOI: 10.1016/j.coph.2007.05.003

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  19 in total

1.  Comparative Plasma Pharmacokinetics of Ceftriaxone and Ertapenem in Normoalbuminemia, Hypoalbuminemia, and Albumin Replacement in a Sheep Model.

Authors:  Jayesh A Dhanani; Benjamin Ahern; Liad Lupinsky; Karen Jackson; Steven C Wallis; Mohd H Abdul-Aziz; Jeffrey Lipman; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

Review 2.  Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.

Authors:  Daniel Gonzalez; Stephan Schmidt; Hartmut Derendorf
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

3.  Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations.

Authors:  Bernard Georges; Jean-Marie Conil; Stéphanie Ruiz; Thierry Seguin; Pierre Cougot; Olivier Fourcade; Georges Houin; Sylvie Saivin
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

Review 4.  Role of microdialysis in pharmacokinetics and pharmacodynamics: current status and future directions.

Authors:  Francine Johansson Azeredo; Teresa Dalla Costa; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2014-03       Impact factor: 6.447

5.  Assessment of the Antibacterial Potential of Biosynthesized Silver Nanoparticles Combined with Vancomycin Against Methicillin-Resistant Staphylococcus aureus-Induced Infection in Rats.

Authors:  Mohammed Awad; Mohamed Yosri; Marwa M Abdel-Aziz; Ahmed M Younis; Nagwa M Sidkey
Journal:  Biol Trace Elem Res       Date:  2021-01-02       Impact factor: 3.738

6.  Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.

Authors:  Estevan Sonego Zimmermann; João Victor Laureano; Camila Neris Dos Santos; Stephan Schmidt; Chakradhar V Lagishetty; Whocely Victor de Castro; Teresa Dalla Costa
Journal:  Antimicrob Agents Chemother       Date:  2015-11-30       Impact factor: 5.191

Review 7.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 8.  A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.

Authors:  Véronique Dartois; Clifton E Barry
Journal:  Bioorg Med Chem Lett       Date:  2013-07-12       Impact factor: 2.823

Review 9.  Antiretroviral pharmacology in mucosal tissues.

Authors:  Corbin G Thompson; Myron S Cohen; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

10.  Soft-tissue penetration of ceftobiprole in healthy volunteers determined by in vivo microdialysis.

Authors:  April Barbour; Stephan Schmidt; Sreedharan Nair Sabarinath; Maria Grant; Christoph Seubert; Donna Skee; Bindu Murthy; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.